CYP17A1-IN-2
CYP17A1-IN-2 is a potent inhibitor of CYP17A1. CYP17A1-IN-2 exhibits anti-proliferative activity against prostate cancer cells. CYP17A1-IN-2 can be used in research related to castration-resistant prostate cancer.
For research use only. We do not sell to patients.
- Formula: C23H21NO3
- Molecular Weight:359.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
CYP17A1 |
In Vitro
CYP17A1-IN-2 (Compound 14c) potently inhibits the proliferation of PC-3 and LNCaP prostate cancer cells, with GI50 values of 8.9 nM and 30.5 nM, respectively[1].
CYP17A1-IN-2 (250 nM) inhibits CYP17A by 31% in mouse testicular homogenates[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 359.42
-
Formula C23H21NO3
-
SMILES
O=C1OC2=CC(O)=CC=C2C3=C1C(CC=C4C5=CN=CC(C)=C5)[C@]4(C)CC3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)